Does active Crohn's disease have decreased intestinal antioxidant capacity?

Journal of Crohn's and Colitis

Volumn 7, Issue 9, 2013, Pages

  Pinto, Marco Antonio S ^a   Lopes, Márcia Soares Mota S ^a   Bastos, Sálua T O ^a   Reigada, Carolina L L ^a   Dantas, Rafael F ^b   Neto, Jaime C B ^b   Luna, Aderval S ^b   Madi, Kalil ^a   Nunes, Tiago ^c   Zaltman, Cyrla ^a  

^a FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antioxidant capacity; Crohn's disease; Glutathione; Glutathione peroxidase; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; MERCAPTOPURINE; MESALAZINE; RETINOL; SELENIUM; STEROID;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL FEATURE; COLON BIOPSY; COLON CANCER; COLONOSCOPY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DEMOGRAPHY; DIETARY INTAKE; DISEASE DURATION; ENDOSCOPY; ENZYME ACTIVITY; FEMALE; HUMAN; INFLAMMATORY CELL; INTESTINE MUCOSA; MALE; NUTRITIONAL STATUS; OBESITY; OUTPATIENT CARE; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; SPECTROPHOTOMETRY; TELECONSULTATION;

ANTIOXIDANT CAPACITY; CROHN'S DISEASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; OXIDATIVE STRESS;

ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; BIOPSY; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CASE-CONTROL STUDIES; COLON; COLONOSCOPY; CROHN DISEASE; ENERGY INTAKE; FEMALE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NUTRITIONAL STATUS; SELENIUM; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84881556644     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.02.010     Document Type: Article

References (58)

1. Sands B.E. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 2004, 126:1518-1532.
2. Satsangi S., Silverberg M.S., Vermeire S., Colombel J.F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006, 55:749-753.
3. Buffinton G.D., Doe W.F. Depleted mucosal antioxidant defenses in inflammatory bowel disease. Free Radic Biol Med 1995, 19(6):911-918.
4. Aghdassi E., Wendland B.E., Steinhart A.H., Wolman S.L., Jeejeebhoy K., Allard J.P. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress: a randomized controlled trial. Am J Gastroenterol 2003, 98:348-353.
5. Catarzi S., Favilli F., Romagnoli C., Marcucci T., Picariello L., Tonelli F., et al. Oxidative state and IL-6 production in intestinal myofibroblasts of Crohn's disease patients. Inflamm Bowel Dis 2011, 17:1674-1684.
6. Genser D., Kang M.H., Vogelsang H., Elmadfa I. Status of lipidsoluble antioxidants and TRAP in patients with Crohn's disease and healthy controls. Eur J Clin Nutr 1999, 53(9):675-679.
7. Koch T.R., Stryker S.J., Telford G.L., Opara E.C. Total antioxidant capacity is reduced in Crohn's disease. Nutr Res 2002, 22:825-833.
8. Ardite E., Sans M., Panés M., Romero F.J., Piqué J.M., Fernández-Checa J.C. Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab Invest 2000, 80:735-744.
9. 2?. Eur J Gastroenterol Hepatol 2008, 20:555-560.
10. Mckenzie S.J., Baker M.S., Buffinton G.D., Doe W.F. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest 1996, 98(1):136-141.
11. Keshavarzian A., Banan A., Farhadi A., Komanduri S., Mutlu E., Zhang Y., et al. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 2003, 52:720-728.
12. Krzystek-Korpacka M., Neubauer K., Berdowska I., Zielinski B., Paradowski L., Gamian A. Impaired erythrocyte antioxidant defense in active inflammatory bowel disease: impact of anemia and treatment. Inflamm Bowel Dis 2010, 16(9):1467-1475.
13. World Health Organization - WHO Physical status: the use and interpretation of anthropometry. WHO Technical Report Series n. 854 1995, WHO, Geneva.
14. Ferreira K.S., Gomes J.C., Bellato C.R., Jordão C.P. Concentrações de selênio em alimentos consumidos no Brasil. Rev Panam Salud Publica 2002, 11(3):172-177.
15. Harris J.A., Benedict F.G. A biometric study of basal metabolism in man 1919, Carnegie Institute of Washington, Washington, DC.
16. Weijs P.J.M., Kruizenga H.M., Van Dijk A.E., van der Meij B.S., Langius J.A., Knol D.L., et al. Validation of predictive equations for resting energy expenditure in adult outpatients and inpatients. Clin Nutr 2008, 27:150-157.
17. Benjamin J., Makharia G.K., Kalaivani M., Joshi Y.K. Nutritional status of patients with Crohn's disease. Indian J Gastroenterol 2008, 27:195-200.
18. US National Academy of Sciences (USA) Dietary reference intakes for vitamin C, vitamin E, selenium and carotenoids 2000, National Academy Press, Washington DC, [506 p.].
19. US National Academy of Sciences (USA) Dietary reference intakes for vitamin a, vitamin k, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc 2001, National Academy Press, Washington DC, [773 p.].
20. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158-169.
21. Lawrence R.A., Burk R.F. Hepatic cytosolic non selenium-dependent glutathione peroxidase activity: its nature and the effect of selenium deficiency. J Nutr 1978, 108:981-987.
22. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977, 83:346-356.
23. Anderson M.E. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 1985, 113:548-555.
24. The Perkim-Elmer Corporation Atomic absorption spectroscopy. Anal Methods 1996, 107-115.
25. Esworthy R.S., Yang L., Frankel P.H., Chu F.F. Epithelium-specific glutathione peroxidase, Gpx2, is involved in the prevention of intestinal inflammation in selenium-deficient mice. J Nutr 2005, 135:740-745.
26. Esworthy R.S., Binder S.W., Doroshow J.H., Chu F.F. Microflora trigger colitis in mice deficient in selenium-dependent glutathione peroxidase and induce Gpx2 gene expression. Biol Chem 2003, 384:597-607.
27. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991, 10:2247-2258.
28. Baeuerle P., Rupec R.A., Pahl H.L. Reactive oxygen intermediates as second messengers of a general pathogen response. Pathol Biol 1996, 44:29-35.
29. Schreck R., Meier B., Männel D.N., Droge W., Baeuerle P.A. Dithiocarbamates as potent inhibitors of NF-kB activation in intact cells. J Exp Med 1992, 175:1181-1194.
30. Eugui E.M., De Lustro B., Rouhafza S., Iinicka M., Lee S.W., Wilhelm R., et al. Some antioxidants inhibit, in a co-ordinate fashion, the production of tumor necrosis factor-α, IL-1b, and IL-6 by human peripheral blood mononuclear cells. Int Immunol 1994, 6:409-422.
31. Kruidenier L., Kuiper I., Lamers C.B., Verspaget H.W. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 2003, 201:28-36.
32. Iantomasi T., Marraccini P., Favilli F., Vincenzini M.T., Ferretti P., Tonelli F. Glutathione metabolism in Crohn's disease. Biochem Med Metab Biol 1994, 53:87-91.
33. Van Der Hulst R.W., Von Meyenfeldt M.F., Deutz N.E.P., Soeters P.B. Glutamine extraction by the gut is reduced in patients with depleted gastrointestinal cancer. Ann Surg 1997, 225:112-121.
34. Miralles-Barrachina O., Savoye G., Belmonte-Zalar L., Hochain P., Ducrotté P., Hecketsweiler B., et al. Low levels of glutathione in endoscopic biopsies of patients with Crohn's colitis: the role of malnutrition. Clin Nutr 1999, 18(5):313-317.
35. Ault J.G., Lawrence D.A. Glutathione distribution in normal and oxidatively stressed cells. Exp Cell Res 2003, 285:9-14.
36. Prohaska J.R., Ganther H.E. Glutathione peroxidase activity of glutathione-S-transferases purified from rat liver. Biochem Biophys Res Commun 1977, 76(2):437-445.
37. Prohaska J.R. The glutathione peroxidase activity of glutathione S-transferases. Biochim Biophys Acta Enzymol 1980, 611(1):87-98.
38. Lawrence R.A., Burk R.F. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 1976, 71:952-958.
39. Samiec P.S., Dahm L.J., Jones D.P. Glutathione S-transferase in mucus of rat small intestine. Toxicol Sci 2000, 54:52-59.
40. Aruoma O.I., Halliwell B. Action of hypochlorous acid on the antioxidant protective enzymes superoxide dismutase, catalase and glutathione peroxidase. Biochem J 1987, 248:973-976.
41. Pigeolet E., Corbisier P., Houbion A., Lambert D., Michiels C., Raes M., et al. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ageing Dev 1990, 51(3):283-297.
42. Lih-Brody L., Powell S.R., Collier K.P., Reddy G.M., Cerchia R., Kahn E., et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996, 41(10):2078-2086.
43. Pigeolet E., Remacle J. Susceptibility of glutathione peroxidase to proteolysis after oxidative alteration by peroxides and hydroxyl radical. Free Radic Biol Med 1991, 11(2):191-195.
44. Grimsrud P.A., Xie H., Griffin T.J., Bernlohr D.A. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem 2008, 283(32):21837-21841.
45. Tinggi U. Selenium: its role as antioxidant in human health. Environ Health Prev Med 2008, 13:102-108.
46. Wingler K., Böcher M., Flohé L., Kollmus H., Brigelius-Flohé R. mRNA stability and selenocysteine insertion sequence efficiency rank gastrointestinal glutathione peroxidase high in the hierarchy of selenoproteins. Eur J Biochem 1999, 259:149-157.
47. Muller C., Wingler K., Brigelius-Flohé R. 3_UTRs of glutathione peroxidases differentially affect selenium-dependent mRNA stability and selenocysteine incorporation efficiency. Biol Chem 2003, 384:11-18.
48. Hinks L.J., Inwards K.D., Lloyd B., Clayton B. Reduced concentrations of selenium in mild Crohn's disease. J Clin Pathol 1988, 41:198-201.
49. Rannem T., Ladefoged K., Hylander E., Hegnhøj J., Jarnum S. Selenium status in patients with Crohn's disease. Am J Clin Nutr 1992, 56:933-937.
50. Rannem T., Ladefoged K., Hylander E., Hegnhøj J., Staun M. Selenium depletion in patients with gastrointestinal diseases: are there any predictive factors?. Scand J Gastroenterol 1998, 33:1057-1061.
51. Ruan E.A., Rao S., Burdick J.S., Stryker S.J., Telford G.L., Otterson M.F., et al. Glutathione levels in chronic inflammatory disorders of the human colon. Nutr Res 1997, 17(3):463-473.
52. Sido B., Hack V., Hochlehnert A., Lipps H., Herfarth C., Dröge W. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut 1998, 42:485-492.
53. Sido B., Seel C., Hochlehnert A., Breitkreutz R., Droge W. Low intestinal glutamine level and low glutaminase activity in Crohn's disease: a rational for glutamine supplementation?. Dig Dis Sci 2006, 51:2170-2179.
54. Ellison I., Richie J.P. Mechanisms of glutathione disulfide efflux from erythrocytes. Biochem Pharmacol 2012, 83:164-169.
55. Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001, 30(11):1191-1212.
56. Lee A.U., Farrell G.C. Mechanism of azathioprine-induced injury to hepatocytes: roles of glutathione depletion and mitochondrial injury. J Hepatol 2001, 35:756-764.
57. Tapner M.J., Jones B.E., Wu W.M., Farrell G.C. Toxicity of low dose azathioprine and 6-mercaptopurine in rat hepatocytes. Roles of xanthine oxidase and mitochondrial injury. J Hepatol 2004, 40:454-463.
58. Mcgrath L.T., Treacy R., Mcclean E., Brown J.H. Oxidative stress in cyclosporin and azathioprine treated renal transplant patients. Clin Chim Acta 1997, 264:1-12.